undamentalytics Newsletter

Utah Medical Products Inc cash flow statement

In fiscal 2025, Utah Medical Products Inc's operations generated $14.7m of cash; it spent $371,000 on capital projects, leaving free cash flow of $14.3m. It returned $4.0m in dividends and $8.4m through buybacks.

Cash flow statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Utah Medical Products Inc: cash flow statement, annual
Fiscal year2009Dec 20092010Dec 20102011Dec 20112012Dec 20122013Dec 20132014Dec 20142015Dec 20152016Dec 20162017Dec 20172018Dec 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Cash from operations7711141215141517171720212122151512
Depreciation and amortisation111111111111111111
Stock-based pay000000000000000000
Capital spending020001032011111000
Free cash flow7611131214141115161719212022151411
Free cash flow after stock pay7611131214141115161619202021141411
Dividends paid3634444434441134444
Share buybacks————————01070202082
Shares issued00021000000010000—

Free cash flow is cash from operations minus capital spending. Free cash flow after stock pay also subtracts stock-based compensation, a real cost to shareholders that the cash flow statement adds back. Dividends, buybacks and shares issued are cash amounts for the period.

Compare with peers

Head to head: ECOR vs UTMDCTSO vs UTMDRVP vs UTMD

More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies

Figures from Utah Medical Products Inc's SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Utah Medical Products Inc.